Press Release July 16, 2021Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma of the Head and Neck 0 0 Share
Company Ticker News July 16, 2021Bristol-Myers' Opdvio/Yervoy Combo Therapy Flunks In Head & Neck Cancer Trial 0 0 Share
Press Release July 16, 2021Bristol Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know 0 0 Share
Press Release July 11, 2021Bristol Myers Squibb (BMY) Stock Moves -0.67%: What You Should Know 0 0 Share
Company Ticker News July 10, 2021Can Gilead Beat Bristol Myers Squibb With Its Cancer CAR-T Therapy? 0 0 Share
Company Ticker News July 10, 2021Bristol-Myers Squibb Is A High Yielding Blue-Chip That Should Appreciate 0 0 Share
Company Ticker News July 10, 2021Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know 0 0 Share
Press Release July 9, 2021Bristol Myers Squibb (BMY) Stock Moves -0.67%: What You Should Know 0 0 Share
